CytomX Therapeutics, Inc.CTMXNASDAQ
Loading
Year-over-year gross profit growth rate
Percentile
P0
Near historical low
vs 3Y Ago
-0.9x
Contraction
Streak
3 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -97.43% |
| Q3 2025 | -68.04% |
| Q2 2025 | -63.36% |
| Q1 2025 | 33.66% |
| Q4 2024 | 13.94% |
| Q3 2024 | 33.12% |
| Q2 2024 | -39.43% |
| Q1 2024 | 55.83% |
| Q4 2023 | 6.61% |
| Q3 2023 | 7.61% |
| Q2 2023 | 5.40% |
| Q1 2023 | 9.34% |
| Q4 2022 | 108.27% |
| Q3 2022 | -24.83% |
| Q2 2022 | 42.18% |
| Q1 2022 | -50.45% |
| Q4 2021 | 3.74% |
| Q3 2021 | 7.98% |
| Q2 2021 | 1.98% |
| Q1 2021 | -2.46% |
| Q4 2020 | -7.95% |
| Q3 2020 | 7.11% |
| Q2 2020 | -66.51% |
| Q1 2020 | 499.02% |
| Q4 2019 | -22.71% |
| Q3 2019 | 18.85% |
| Q2 2019 | -69.43% |
| Q1 2019 | 157.04% |
| Q4 2018 | -8.30% |
| Q3 2018 | -41.38% |
| Q2 2018 | 50.44% |
| Q1 2018 | -47.61% |
| Q4 2017 | 12.13% |
| Q3 2017 | 175.87% |
| Q2 2017 | -24.89% |
| Q1 2017 | 85.79% |
| Q4 2016 | 81.59% |
| Q3 2016 | 11.64% |
| Q2 2016 | 39.18% |
| Q1 2016 | 11.82% |